Reasons why Editas Medicine Inc’s (NASDAQ:EDIT) fundamentals are futile
In yesterday’s Wall Street session, Editas Medicine Inc (NASDAQ:EDIT) shares traded at $7.80, up 12.72% from the previous session. 18 analysts cover Editas Medicine Inc (NASDAQ:EDIT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $30.00 and a […]
Do investors have a safe investment in Editas Medicine Inc. (NASDAQ:EDIT)?
The price of Editas Medicine Inc. (NASDAQ:EDIT) shares last traded on Wall Street fell -1.48% to $8.65. Based on available information, 19 analysts follow Editas Medicine Inc. (NASDAQ:EDIT). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $30.00 and a low of […]
Stocks of Editas Medicine Inc. [EDIT] are gaining investors’ attention: here’s why
Stocks of Editas Medicine Inc. (NASDAQ:EDIT) traded higher last session on Wall Street, up 0.49% to $8.28. According to the data, Editas Medicine Inc. (NASDAQ:EDIT) has 19 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $30.00 and […]
